Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Avadel Pharmaceuticals Plc (AVDL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7400
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells its products in the US, France, and Ireland. The company operates in St. Louis, Missouri, and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc (AVDL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avadel Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Avadel Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avadel Pharmaceuticals Plc, Medical Equipment, Deal Details 10
Partnerships 10
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 10
Merger 11
Flamel Technologies Merges with Avadel Pharma 11
Debt Offering 12
Avadel Pharma Raises USD143.8 Million in Private Placement of 4.5% Notes Due 2023 12
Asset Transactions 13
Cerecor to Acquire Pediatric Business from Avadel Pharma 13
Acquisition 14
Flamel Technologies Acquires FSC Holdings 14
Avadel Pharmaceuticals Plc – Key Competitors 16
Avadel Pharmaceuticals Plc – Key Employees 17
Avadel Pharmaceuticals Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Aug 07, 2018: Avadel Pharmaceuticals reports second quarter 2018 financial results 20
May 02, 2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results 22
Mar 08, 2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results 24
Nov 08, 2017: Avadel Pharmaceuticals Reports Third Quarter 2017 Results 25
Aug 08, 2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results 27
May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 29
Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 30
Corporate Communications 32
Mar 22, 2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer 32
Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 33
Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer 34
Other Significant Developments 35
Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Avadel Pharmaceuticals Plc, Medical Equipment, Key Facts, 2017 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avadel Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Deals By Market, 2012 to YTD 2018 8
Avadel Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 10
Flamel Technologies Merges with Avadel Pharma 11
Avadel Pharma Raises USD143.8 Million in Private Placement of 4.5% Notes Due 2023 12
Cerecor to Acquire Pediatric Business from Avadel Pharma 13
Flamel Technologies Acquires FSC Holdings 14
Avadel Pharmaceuticals Plc, Key Competitors 16
Avadel Pharmaceuticals Plc, Key Employees 17
Avadel Pharmaceuticals Plc, Subsidiaries 18

List of Figures
Avadel Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avadel Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ComOps Limited (COM):企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BelAZ:企業の戦略・SWOT・財務情報
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Shin Kong Financial Holding Co Ltd (2888):企業の財務・戦略的SWOT分析
    Shin Kong Financial Holding Co Ltd (2888) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Advanced Micro Devices, Inc.:戦略・SWOT・企業財務分析
    Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SynDevRx Inc (SDX) is a drug development company that develops treatments for cancer and metabolic dysfunction. The company offers lead compound SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active novel small molecule fumagillol derivative in vivo. Its servic …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • SEEK Limited:企業のM&A・事業提携・投資動向
    SEEK Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEEK Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Hdfc Bank Ltd
    Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pousadas de Portugal:企業の戦略・SWOT・財務情報
    Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report Summary Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務分析
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CHS Inc (CHSCP):石油・ガス:M&Aディール及び事業提携情報
    Summary CHS Inc. (CHS) is an integrated agribusiness company, which provides grain, foods and energy resources to businesses and consumers. It is a cooperative owned by farmers and ranchers and their member cooperatives across the US. The company provides a broad range of products and services, from …
  • Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Vanguard Natural Resources, Inc (Vanguard) is an independent oil and gas company with upstream operations. It acquires, produces, and develops oil and natural gas properties. The compa …
  • Mirabilis Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a healthcare equipment company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, preg …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Diffusion Pharmaceuticals Inc (DFFN):製薬・医療:M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Australian Gas Networks Ltd:電力:M&Aディール及び事業提携情報
    Summary Australian Gas Networks Ltd (Australian Gas Networks), formerly Envestra Ltd is an oil and gas company that distributes and transports natural gas. The company's services include managing the haulage of gas through each network, operation and maintenance of gas network, design an constructio …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆